“In GC, CBR3-AS1 and PCA3 may be utilized as therapeutic targets and prognostic biomarkers, respectively” Researchers, led by first author Parisa Najari and corresponding author Reza Safaralizadeh ...
A new research paper was published in Volume 16 of Genes & Cancer on May 9, 2025, titled "Evaluation of LncRNAs CBR3-AS1 and PCA3 expression in Gastric cancer and their correlation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback